ILA 23.1
(-2.94%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | -7.13 Million | 1.05 Million | 39 Million | - |
Cost of Revenue | - | - | - | - |
Gross Profit | -7.13 Million | 1.05 Million | 39 Million | - |
Operating Expenses | 2.08 Million | 4.32 Million | 12.19 Million | 1.52 Million |
Selling, General and Administrative Expenses | 3.59 Million | 3.99 Million | 12.19 Million | 1.52 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | -1.5 Million | - | - | - |
Cost and Expenses | 2.08 Million | 4.32 Million | 12.19 Million | 1.52 Million |
Operating Income | -9.22 Million | -3.26 Million | 26.8 Million | -1.52 Million |
Interest Expense | - | - | - | - |
Income Tax Expense | 2.43 Million | 786 Thousand | 6.24 Million | -1.31 Million |
Earnings before Tax | -9.1 Million | -3.22 Million | 26.8 Million | -1.52 Million |
Net Income | -6.67 Million | -2.43 Million | 20.55 Million | -1.52 Million |
Earnings Per Share Basic | -0.03 | -0.01 | 0.10 | -0.01 |
Earnings Per Share Diluted | -0.03 | -0.01 | 0.10 | -0.01 |
Weighted Average Shares Outstanding | 253.05 Million | 243.92 Million | 201.5 Million | 250.89 Million |
Weighted Average Shares Outstanding (Diluted) | 253.04 Million | 252.75 Million | 203.84 Million | 250.89 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | - |
EBIT Margin | - | 1.53 | -0.00 | - |
Profit Margin | 0.93 | -2.31 | 0.53 | - |
EBITDA | - | - | - | - |
Earnings Before Tax Margin | 1.29 | -3.09 | 0.69 | - |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | -1.45 Million | -7.13 Million | -7.4 Million | 270 Thousand | 1.05 Million | 1.05 Million |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | -1.45 Million | -7.13 Million | -7.4 Million | 270 Thousand | 1.05 Million | 1.05 Million |
Operating Expenses | 1.4 Million | 2.08 Million | 1.34 Million | 748 Thousand | 2 Million | 4.32 Million |
Selling, General and Administrative Expenses | 1.59 Million | - | 1.77 Million | 1.82 Million | 2 Million | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -191 Thousand | - | -437 Thousand | - | - | - |
Cost and Expenses | 1.4 Million | 2.08 Million | 1.34 Million | 748 Thousand | 2 Million | 4.32 Million |
Operating Income | -2.85 Million | -10.73 Million | -9.18 Million | -1.55 Million | -943 Thousand | -3.26 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 685 Thousand | 2.43 Million | 2.09 Million | 342 Thousand | 262 Thousand | 786 Thousand |
Earnings before Tax | -2.79 Million | -9.1 Million | -8.69 Million | -415 Thousand | -898 Thousand | -3.22 Million |
Net Income | -2.1 Million | -6.67 Million | -6.59 Million | -73 Thousand | -636 Thousand | -2.43 Million |
Earnings Per Share Basic | -0.01 | - | -0.03 | -0.00 | -0.00 | - |
Earnings Per Share Diluted | -0.01 | - | -0.03 | -0.00 | -0.00 | - |
Weighted Average Shares Outstanding | 263.37 Million | 253.05 Million | 252.9 Million | 252.75 Million | 217.65 Million | 243.92 Million |
Weighted Average Shares Outstanding (Diluted) | 263.37 Million | 253.04 Million | 252.89 Million | 252.75 Million | 247.93 Million | 252.75 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | -1.08 | - | -0.63 | 6.74 | 0.54 | - |
Profit Margin | 1.45 | 0.93 | 0.89 | -0.27 | -0.60 | -2.31 |
EBITDA | 1.56 Million | - | 4.68 Million | 1.81 Million | 569 Thousand | - |
Earnings Before Tax Margin | 1.97 | 1.50 | 1.24 | -5.74 | -0.89 | -3.09 |
MARBU
PUMU
CRTM
ZAIRF
AHELF
ACNI